Pentadentate MRI Contrast Agent

Technical Description

This invention presents a novel pent dentate chelate-based contrast agent for MRI, utilizing a new water-soluble ligand to enhance T1-weighted imaging. It aims to improve image contrast and diagnostic accuracy.

Problems Addressed

  • Risky Nephrogenic Systemic Fibrosis(NSF) from Gd (III) ion leaching
  • Manganese Toxicity issues
  • Mn (II) CA withdrawal
  • Coordination Complex Stability

Tech Features

  • Piperidine-carboxylate ligand
  • Provide novel metalcomplexes
  • Water soluble Mn(II)complex
  • Novel T1-weight MRI

Target Audience

  • Medical Imaging Industry
  • Pharmaceutical Industry
  • Diagnostic Imaging Centre’s
  • MRI Equipment Manufactures
  • Biomedical Research Institutions
Tech ID: P21-1250 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
 Craft Display
×

P21-1250

DOWNLOAD

Send download link to email.

Contact For Licensing

Lalit Ambastha

+91- 9811367838

Dr. Medha Kaushik

+91- 6359777555

tech@ipbazzaar.com

Connect With Us

Subscribe to Our Latest Updates!

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Intellectual Property Rights | Technology Monetization | IP Merger & Acquisition- IP Bazzaar will use the information you provide on this form to be in touch with you and to provide updates and marketing.